IMP-1734
N/A
Report date: 2026/05/13 20:02:10
NME
Base Information
Drug NameIMP-1734
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Impact Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesEikon Therapeutics IncShanghai Impact Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A